Delivery Order SPE2DB20D1100-SPE2DB25FD7D5
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,696.72 to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG Inhaler 10.7GM pharmaceutical products. This firm fixed-price, non-set-aside delivery order was awarded on July 24, 2025, with an ultimate completion date of July 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,828.45 to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG Inhaler 10.7GM pharmaceutical products. The contract is a firm fixed price delivery order with an ultimate completion date of July 21, 2025, and was awarded on July 18, 2025. No set-aside designation was used in this competitive award. Performance will take place in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a $1,393.12 delivery order to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG Inhaler 10.7GM, a respiratory medication product. This competitive, firm fixed-price delivery order was issued on July 31, 2025, with an ultimate completion date of August 1, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, indicating it was awarded through open competition....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,152.19 firm fixed-price contract is for the supply of AIRSUPRA 90-80 MCG INHALER 10.7GM, a medical product, with a performance period ending on December 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as...
- The Defense Logistics Agency awarded a delivery order valued at $1,740.00 to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG Inhaler 10.7GM, with an ultimate completion date of July 21, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to the prime contractor's corporate office located in Conshohocken, Pennsylvania. The contract represents a pharmaceutical supply delivery under DLA's medical procurement operations, which support military and...
- This federal contract award, valued at $2,992.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AIRSUPRA 90-80 MCG INHALER 10.7GM, a medical product, with a completion date of June 6, 2025. The contract is a firm fixed-price delivery order and is not set aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the delivery of 4565752816 AIRSUPRA 90-80 MCG INHALER 10.7GM, a pharmaceutical product. The delivery order has a ceiling value of $14,793.27 and a firm-fixed price pricing type. The contract has an ultimate completion date of September 11, 2024. Amerisourcebergen is a major supplier of pharmaceutical and medical...
- This is a $3,971.18 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AIRSUPRA 90-80 MCG INHALER 10.7GM, a pharmaceutical product, with an ultimate completion date of May 30, 2025. The contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product AIRSUPRA 90-80 MCG INHALER 10.7GM. The contract has a ceiling value of $1,974.40 and a performance period ending on May 15, 2024. This award is a part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December...
- This is a $2,651.89 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of AIRSUPRA 90-80 MCG INHALER 10.7GM medical devices and has a completion date of February 7, 2024. This delivery order is part of a larger Indefinite Delivery Contract valued at $999,999,999 that Amerisourcebergen holds with DLA Troop Support...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD7D5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,230.62 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Airsupra 90-80 mcg inhaler in 10.7-gram units. This firm fixed-price, non-set-aside contract is scheduled for completion by July 30, 2025, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle running through December 2026 that authorizes the company to supply a comprehensive range of medications and medical supplies to military healthcare systems worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contract awards with the DLA encompasses a wide spectrum of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. All of the company's reviewed contract awards, including this delivery order, were competitively awarded without set-aside designations, demonstrating AmerisourceBergen's capability to meet federal procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 7/29/25 |